Friday, 6 November 2026European Markets

Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source

Source documentYahoo Finance· March 22, 2026

VIG vs NOBL: Which Dividend ETF Should You Buy Now?

View original at finance.yahoo.com

VIG vs NOBL: Which Dividend ETF Should You Buy Now? Both the Vanguard Dividend Appreciation ETF(NYSEMKT:VIG) VIG and the ProShares S&P 500 Dividend Aristocrats ETF (NYSEMKT:NOBL) target companies with a proven record of growing dividends…

Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

Data points we hold from this source

Exxon Mobil Corporation · portfolio weight nobl

1.7 percent

What we know · the intelligence behind this page

Live from the substrate

What we're seeing

Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves

Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).

Our read on the data ›

Signals we're tracking

EPKINLY Regulatory-Clinical Success Cascade

High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.

Patterns we're watching ›

Where sources disagree

Ford Motor Company

Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.

We flag conflicts openly ›

Recently verified

✓ Checked against the original source

4,996

facts traced to their source — and we flag the ones that don't hold up.

101 entities tracked4,996 facts checked against source5,552 source documents archived

Query this data → isubstrate.com

VIG vs NOBL: Which Dividend ETF Should You Buy Now? — Source | Via News | ViaNews EU